NASDAQ:EPHY Epiphany Technology Acquisition (EPHY) Stock Price, News & Analysis → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free EPHY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.09▼$10.1050-Day Range$9.84▼$10.1052-Week Range$9.71▼$10.10Volume30,183 shsAverage Volume62,000 shsMarket Capitalization$515.98 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Epiphany Technology Acquisition alerts: Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... About Epiphany Technology Acquisition Stock (NASDAQ:EPHY)Epiphany Technology Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Palo Alto, California.Read More Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... EPHY Stock News HeadlinesJune 25, 2023 | thestreet.com4 Hot Acquisition Targets for Cisco Systems After It Shuns FireEyeMay 18, 2023 | wsj.comAurora Technology Acquisition Corp. Cl AApril 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.December 12, 2022 | finance.yahoo.comEpiphany Technology Acquisition Corp. Announces No Contribution Will be Made to Trust Account in Connection with its ExtensionJune 2, 2022 | markets.businessinsider.comShort Volatility Alert: Epiphany Technology Acquisition Corp.February 13, 2022 | nasdaq.comWhat Kind Of Shareholders Hold The Majority In Epiphany Technology Acquisition Corp.'s (NASDAQ:EPHY) Shares?December 13, 2021 | finance.yahoo.comSecurity Industry Pioneer Art Coviello Joins Cybereason Board of DirectorsSeptember 30, 2021 | investing.comEpiphany Technology Acquisition Corp (EPHY)April 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.August 21, 2021 | barrons.comEpiphany Technology Acquisition Corp. Cl AAugust 20, 2021 | news.yahoo.comSingle people are ditching love and raising kids with platonic friendsSee More Headlines Receive EPHY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Epiphany Technology Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:EPHY CUSIPN/A CIK1827248 Webepiphanytechacquisition.com Phone619-736-6855FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$7.21 million Net MarginsN/A Pretax MarginN/A Return on Equity-62.53% Return on Assets2.96% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.14 per share Price / Cash Flow71.59 Book Value($0.49) per share Price / Book-20.60Miscellaneous Outstanding Shares51,112,000Free Float40,583,000Market Cap$515.98 million OptionableNot Optionable Beta0.02 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Peter W. Bell Ph.D. (Age 57)Co-CEO, CFO & Director Mr. Ross Haghighat (Age 58)Co-CEO & Director Key CompetitorsEquity Distribution AcquisitionNYSE:EQDJOFF Fintech AcquisitionNASDAQ:JOFFNabors Energy Transition Corp. IINASDAQ:NETDFusion Acquisition Corp. IINYSE:FSNBAres Acquisition Co. IINYSE:AACTView All Competitors This page (NASDAQ:EPHY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Epiphany Technology Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
